RRoche Read More Roche’s BTK Drug Fenebrutinib Shines in Multiple Sclerosis Study2026-03-06 Roche RHHBY recently announced that the late-stage study, FENhance 1, evaluating fenebrutinib for relapsing multiple sclerosis (RMS), met…
RRoche Read More Roche’s BTK Drug Fenebrutinib Shines in Multiple Sclerosis Study2026-03-03 Roche RHHBY recently announced that the late-stage study, FENhance 1, evaluating fenebrutinib for relapsing multiple sclerosis (RMS), met…